Relationship between white blood cell count and clinical classification in patients with coronary heart disease
Author:
Affiliation:

1.Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University,Harbin, Heilongjiang 150001, China;2.The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin, Heilongjiang 150001, China;3.The Key Laboratory of Panvascular Diseases, Harbin, Heilongjiang 150001, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [20]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To study the relationship between white blood cell count and clinical classification in patients with coronary heart disease and its clinical significance. Methods A total of 301 patients diagnosed with coronary heart disease in the Second Affiliated Hospital of Harbin Medical University from January 2022 to December 2023 were selected as the research subjects, and divided into stable angina pectoris (SAP) group and acute coronary syndrome (ACS) group based on their clinical manifestations and results of electrocardiogram, the differences of general data, biochemical indexes and cardiovascular indexes between the two groups were compared. Spearman correlation analysis was used to analyze the relationship between white blood cell count, neutrophil count and cardiovascular related indicators, including troponin I, N-terminal pro-brain natriuretic peptide (NT-proBNP), ejection fraction, left ventricular end-diastolic diameter (LVEDD), left atrial diameter, Gensini score, etc. ROC curve was employed to determine the cut-off point for diagnosing ACS and SAP classification of coronary heart disease based on white blood cell count, and dividing patients into a group with normal white blood cell level and a group with above normal white blood cell level based on this cut-off point, the differences between the two groups were compared. Results The ratio of hyperlipidaemia history, white blood cell count, neutrophil count, C-reactive protein, platelet count, total cholesterol (TC), low density lipoprotein cholesterol (LDLC), troponin I, NT-proBNP and Gensini score in the ACS group were significantly higher than those in the SAP group (all P<0.05), while the ratio of aspirin use, the ratio of statin use, and ejection fraction in the ACS group were lower than those in the SAP group (all P<0.05). Spearman correlation analysis results showed that white blood cell count was positively correlated with C-reactive protein (r=0.443, P<0.001), troponin I (r=0.333, P<0.001), NT-proBNP (r=0.245, P<0.001) and Gensini score (r=0.341, P<0.001), but negatively correlated with LVEDD (r=-0.212, P<0.001). Similarly, neutrophil count was positively correlated with C-reactive protein (r=0.430, P<0.001), troponin I (r=0.325, P<0.001), NT-proBNP (r=0.292, P<0.001) and Gensini score (r=0.353, P<0.001), but negatively correlated with LVEDD ( r=-0.175, P=0.002). The cut-off point of white blood cell count in the diagnosis of ACS was 9.35×109 L-1 (sensitivity was 56.7%, specificity was 93.1% ). The patients were divided into normal white blood cell level group (n=202) and above normal white blood cell level group (n=99). Hyperlipidemia, smoking history, TC, LDLC, C-reactive protein, troponin I, NT-proBNP and Gensini scores in above normal white blood cell level group were significantly higher than those in the normal white blood cell level group (all P<0.05), while LVEDD was lower than that in the normal white blood cell level group (all P<0.05). Conclusion White blood cell count can easily identify the high-risk type of coronary heart disease, and the cut-off point for the diagnosis of ACS is 9.35×109 L-1.

    Reference
    [1] ZHAO D, LIU J, WANG M, et al.Epidemiology of cardiovascular disease in China:current features and implications.Nat Rev Cardiol, 9,6(4):203-212.
    [2] 杨启娟, 苏晓灵.炎症因子与急性心肌梗死的研究进展.中国动脉硬化杂志, 3,1(7):639-644.YANG Q J, SU X L.Research progress on inflammatory factor and acute myocardial infarction.Chin J Arterioscler, 3,1(7):639-644.
    [3] JANSEN I, CAHALANE R, HENGST R, et al.The interplay of collagen, macrophages, and microcalcification in atherosclerotic plaque cap rupture mechanics.Basic Res Cardiol, 4,9(2):193-213.
    [4] MADJID M, FATEMI O.Components of the complete blood count as risk predictors for coronary heart disease:in-depth review and update.Tex Heart Inst J, 3,0(1):17-29.
    [5] LIU Y H, CHEN S C, LEE W H, et al.Components of the complete blood count as a risk predictor for incident hypertension in a large taiwanese population follow-up study.Circ J, 3,7(3):456-462.
    [6] 李卫红.冠状动脉硬化易损斑块影响因素与急性冠状动脉综合征的关系.中华临床医师杂志(电子版), 3,7(12):5606-5608.LI W H.Relationship between factors influencing coronary atherosclerotic vulnerable plaque and acute coronary syndrome.Chin J Clinicians (Electron Ed), 3,7(12):5606-5608.
    [7] MAZZOTTA C, BASU S, GOWER A C, et al.Perivascular adipose tissue inflammation in ischemic heart disease.Arterioscler Thromb Vasc Biol, 1,1(3):1239-1250.
    [8] BRAUNWALD E.Will primordial prevention change cardiology?.Eur Heart J, 3,4(35):3307-3308.
    [9] ZHENG W C, CHAN W, DART A, et al.Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease.Eur Heart J Cardiovasc Pharmacother, 4,0(1):53-67.
    [10] 范骎, 陶蓉, 张瑞岩, 等.炎症反应在易损斑块中的作用及其机制研究进展.中国动脉硬化杂志, 9,7(4):301-306.FAN Q, TAO R, ZHANG R Y, et al.Research progress on the role of inflammatory response in vulnerable plaque and its mechanism.Chin J Arterioscler, 9,7(4):301-306.
    [11] CAGNINA A, CHABOT O, DAVIN L, et al.Atherosclerosis, an inflammatory disease.Rev Med Liege, 2,7(5/6):302-309.
    [12] DRING Y, VAN DER VORST E P C, WEBER C.Targeting immune cell recruitment in atherosclerosis.Nat Rev Cardiol, 2024.DOI:10.1038/s41569-024-01023-z.
    [13] 王钧, 李幸, 贾璐, 等.脂蛋白(a)水平与冠心病患者易损斑块独立相关.中国动脉硬化杂志, 9,7(4):293-300.WANG J, LI X, JIA L, et al.Lipoprotein(a) level is independently correlated with vulnerable plaques in patients with coronary heart disease.Chin J Arterioscler, 9,7(4):293-300.
    [14] SHAH B, BABER U, POCOCK S J, et al.White blood cell count and major adverse cardiovascular events after percutaneous coronary intervention in the contemporary era:insights from the Paris study (patterns of non-adherence to anti-platelet regimens in stented patients registry).Circ Cardiovasc Interv, 7,0(9):e004981.
    [15] STEWART R A, WHITE H D, KIRBY A C, et al.White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.Circulation, 5,1(14):1756-1762.
    [16] SHAH P K, GALIS Z S.Matrix metalloproteinase hypothesis of plaque rupture:players keep piling up but questions remain.Circulation, 1,4(16):1878-1880.
    [17] LIBBY P, BURING J E, BADIMON L, et al.Atherosclerosis.Nat Rev Dis Primers, 9,5(1):56.
    [18] TRAN H V, ERSKINE N A, NGUYEN H L, et al.Increase in white blood cell count is associated with the development of atrial fibrillation after an acute coronary syndrome.Int J Cardiol, 9,4:138-143.
    [19] ALKHALFAN F, NAFEE T, YEE M K, et al.Relation of white blood cell count to bleeding and ischemic events in patients with acute coronary syndrome (from the atlas ACS 2-TIMI 51 trial).Am J Cardiol, 0,5(5):661-669.
    [20] ZHANG Q, WANG Y F, HU X, et al.Association of serum cardiac troponin I and severity of coronary stenosis in patients with varied renal functions:a retrospective cohort study.BMJ Open, 2,2(3):e054722.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

TANG Chaohui, PENG Xiang, TIAN Jinwei, GU Xia. Relationship between white blood cell count and clinical classification in patients with coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(12):1051-1056.

Copy
Share
Article Metrics
  • Abstract:50
  • PDF: 1820
  • HTML: 0
  • Cited by: 0
History
  • Received:April 12,2024
  • Revised:July 31,2024
  • Online: January 06,2025
Article QR Code